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Abstract. Monosynaptic responses of ventral roots of spinal cord in experimental diabetes mellitus. 
Rodinsky A.G., Zinov’yeva E.G., Romanenko L.A. In intact rats and rats with experimental diabetes mellitus (DM) 
threshold, chronaxia, latent period, duration and amplitude of monosynaptic discharges of ventral root, as well as 
refractory periods in response to its paired stimulation were analyzed. There as found out increase in the threshold of 
excitability by 2 times (p<0,01), increases in the total duration of action potential by 25% (p<0,001), and latent period 
by 32% (p<0,05) and decrease in its amplitude by 11% (p>0,05). In the response to paired stimulation there was  
obtained a significant increase in the amplitude of action potential under experimental DM in the interval of 2-5 ms  
between stimulation. There was made a conclusion that in DM a decrease in excitability and conductivity of the spinal 
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